1. Introduction {#s0005}
===============

Adipose tissues play key roles in regulating lipid metabolism, glucose homeostasis and inflammation ([@bb0025]; [@bb0065]). White adipose tissues (WAT) mainly store energy surplus in form of triglyceride, and also function as a major endocrine organ through secreting adipokines ([@bb0175]). Levels of WAT adipokines, such as resistin and leptin, were correlated with risks of dementia and neurodegenerative diseases such as Alzheimer\'s disease (AD), as well as neurological and neurovascular disorders ([@bb0010]; [@bb0035]; [@bb0170]). Brown adipose tissues (BAT) are specialized in breaking down lipids to generate heat mediated by Ucp1 (Uncoupling protein 1) to defend against cold ([@bb0220]). BAT have also been reported to secrete endocrine factors to modulate systemic energy metabolism ([@bb0180]; [@bb0290]). The thermogenic function of brown adipocytes makes BAT expansion a promising strategy to offset energy surplus and counteract obesity, but whether BAT expansion comes with side effects remains unexplored.

Peripheral neuropathy is a class of disease affecting peripheral nerves, often involves axonal abnormality or demyelination ([@bb0265]; [@bb0270]). Axons are normally enclosed by a myelin sheath with multilayered membrane, which functions as an insulator to greatly increase the velocity of axonal impulse conduction ([@bb0135]). Myelination of axons is performed by oligodendrocytes in the central nervous system (CNS) and by Schwann cells in the peripheral nervous system (PNS). Neuro-inflammation is a common factor accounting for the pathogenesis of multiple neurodegenerative diseases ([@bb0195]), including Alzheimer\'s Disease ([@bb0205]), Parkinson\'s Disease ([@bb0020]), and peripheral neuropathies ([@bb0195]; [@bb0205]). However, what causes inflammation of the peripheral nerve is incompletely understood.

Lkb1 (Liver kinase b1) is a serine/threonine kinase involved in regulating cellular energy metabolism and immune response ([@bb0235]; [@bb0085]). Lkb1 directly phosphorylates and activates AMP-activated protein kinase (AMPK), and subsequently regulates the mammalian target-of-rapamycin (mTOR) pathway ([@bb0300]; [@bb0240]). Recent studies have begun to uncover the function of Lkb1 in adipocytes. Specifically, aP2-Cre induced knockout of Lkb1 in preadipocytes results in lipodystrophy and premature death of the KO mice ([@bb0325]). However, *adiponectin-Cre* (*adipoq-Cre*) mediated deletion of *Lkb1* in mature adipocytes (*Ad-Lkb1* mice) leads to expansion of BAT without significant alterations of WAT mass ([@bb0230]). The young *Ad-Lkb1* mice exhibit elevated energy expenditure due to increased thermogenic function of BAT ([@bb0230]). Hence, Lkb1 plays distinct roles in different adipose tissues, as well as at different stages of adipogenesis.

Recent research has established an association between WAT expansion and inflammation ([@bb0030]; [@bb0160]). Interestingly, Wernstedt et al. reported that proinflammatory signaling in the adipocyte is required for proper remodeling and expansion of WAT ([@bb0015]). However, whether inflammation is also associated with BAT expansion in *Ad-Lkb1* KO mice during postnatal growth, and whether inflammation of BAT exerts any side effects remains unclear. Here, we performed microarray analysis to pinpoint inflammation as a key feature of hypertrophic BAT in the *Ad-Lkb1* mouse model. Strikingly, we show that the *Ad-Lkb1* mice develop hindlimb paralysis starting at 8-month old (middle age). As Adipoq-Cre only drives deletion of Lkb1 in adipocytes and induces hypertrophy of BAT but not WAT, development of hindlimb paralysis in the *Ad-Lkb1* mouse makes it a good model to study the long-term consequences of BAT inflammation.

2. Materials and Methods {#s0010}
========================

2.1. Animals {#s0015}
------------

All procedures involving mice were approved by Institutional Animal Care and Use Committee. The *Adipoq-Cre* (stock \#010803, RRID: IMSR_JAX:010803), *Lkb1*^*flox/flox*^ (stock \#014143, RRID: IMSR_JAX:014143) and *mTOR* ^*flox/flox*^ (stock \#011009, RRID: IMSR_JAX:011009) mice were purchased from Jackson Laboratory (Bar Harbor, ME). Mice were housed in the animal facility with free access to water and standard rodent chow food (TD.06414 Harlan). Male and female mice \> 6-month-old were used unless otherwise indicated. PCR genotyping was done using protocols described by the supplier. For macrophage deletion treatment, Clodrosome or Vehicle was purchased from Encapsula NanoSciences company, which was delivered by intraperitoneal (IP) injection with 200uL (5 mg/ml) per mouse (8-months old, female) for initial injection and 100 μl each subsequent injection once weekly as described ([@bb0070]). Rapamycin (Calbiochem and LC Laboratories) was administered by IP injection at 4 mg/kg ([@bb0315]). It was reconstituted in absolute ethanol at 10 mg/ml or 1 diluted in 5% Tween-80 (Sigma) before injection.

2.2. Foot Print (Paralysis) Measurement {#s0020}
---------------------------------------

To measure the locomotion of WT and KO mice, both fore-paws were immersed in red ink and hind limbs were immersed in blue ink, then the mice were allowed to walk freely on white filter paper (Whatman).

2.3. Treadmill Measurement {#s0025}
--------------------------

Mouse ran treadmill test performed as described by [@bb0320]. In brief, mouse was trained on treadmill (Eco 3/6 treadmill; Columbus Instruments, Columbus, OH, USA) with a fixed 10% slope, at constant 10 m/min speed for 5 min daily for consecutively 3 days before test. On the exercise testing day, animals ran on the treadmill at 10 m/min for 5 min and the speed was increased by 2 m/min every 2 min until they were exhausted or a maximal speed of 30 m/min was achieved. The exhaustion was defined as the inability of the animal to run on the treadmill for 10 s despite mechanical prodding. Running time and maximum speed achieved was measured whereas running distance was calculated.

2.4. Hematoxylin-Eosin (H&E) and Immunostaining {#s0030}
-----------------------------------------------

Spinal cord, sciatic nerve, TA, Gas, EDL and SOL muscle tissues from the WT and *Ad-Lkb1* KO mice were dissected and frozen immediately in OCT compound. Frozen samples were cross-sectioned (8--12 μm) using a Leica CM1850 cryostat. For H&E staining, the sections were stained in hematoxylin (30 min), rinsed in running tap water and stained in eosin (1 min). Immunostaining was performed as previously described ([@bb0225]). Briefly, sections were fixed in 4% PFA (except for fiber type detection), incubated in blocking buffer (5% goat serum, 2% BSA, 0.2% triton X-100 and 0.1% sodium azide in PBS) for 1 h, followed by incubation with the primary antibodies diluted in blocking buffer overnight. After washing with PBS, the samples were incubated with secondary antibodies and DAPI (diluted in PBS) for 45 min at room temperature. Fluorescent images were captured as single channel grayscale images using a Leica DM 6000B fluorescent microscope with a 20 × objective (NA 0.70) and assembled in Photoshop. Images for WT and KO samples were captured using identical parameters and both control and KO images were adjusted identically in Photoshop.

2.5. Transmission Electron Microscopy (TEM) {#s0035}
-------------------------------------------

The sciatic nerve and spinal cord were fixed in 2.5% glutaraldehyde for 30 min and cut into 1 × 2-mm blocks. The blocks continued fixation in 2.5% glutaraldehyde for 1 h, followed by fixation in 2% osmium tetroxide for 1 h. All the fixatives were made with 0.1 M cacodylate buffer. After washing, the blocks were dehydrated in a graded ethanol series and then embedded in Epon Generic Resin. The sections with a thickness of about 90 nm were prepared with uranyl acetate and lead citrate stain and examined with a transmission electron microscope (Gatan Digital microscopy). The myelinated axons were counted by Image J (National Institutes of Health) and abnormal myelinated axons were characterized by de-compaction of myelin sheath, irregular shapes with myelin infoldings, or axonal swelling. The g-ratio and axon diameter were also analyzed by image J ([@bb0275]). In brief, g-ratio of each axon was calculated by the perimeter of axons (inner) divided by the perimeter of corresponding fibers (outer) to eliminate the bias on circularity. Axonal diameters were normalized by perimeters through equation: diameter = perimeter/*π*. For each mouse, three random images were counted 20--30 axons randomly. This procedure allows for inclusion of irregularly shaped axons and fibers and helps to eliminate biased measurement of diameters based on circularity.

2.6. Electrophysiological Recordings and Analysis {#s0040}
-------------------------------------------------

Sciatic nerves rapidly excised from the body were immediately placed in Krebs\' solution (mM): 124 NaCl, 2 KCl, 1.2 KH~2~PO~4~, 1.3 MgSO~4~, 2 CaCl~2~, 10 dextrose, and 10 sodium ascorbate, bubbled continuously with 95% O~2~--5% CO~2~ to maintain pH of 7.2--7.4. After an hour of recovery, sciatic nerves were placed in a recording chamber for electrophysiological recordings, as detailed in past publications ([@bb0255]; [@bb0310]; [@bb0245]). In short, the chamber is composed of a central compartment circulating oxygenated Krebs\' solution (2 ml/min) at 37 °C, two neighboring 'sucrose gap' compartments circulating isotonic sucrose (320 mM) (1 ml/min) and two outer compartments containing isotonic KCl (120 mM). Extracellular stimulating and recording electrodes were positioned such that action potentials were conducted and measured across the central compartment. Compound action potentials (CAPs), the spatio-temporal summation of all single axon action potentials, were generated by applying a supramaximal stimulus (110% of the maximal stimulus) in the form of 0.1 ms constant current unipolar pulses every 3 s and were recorded in real time. A bridge amplifier (Neurodata Instruments) was used for data acquisition and further analysis was accomplished using custom Labview software (National Instruments) installed on a Dell PC.

2.7. Microarray Analysis {#s0045}
------------------------

RNA was extracted from 12-wk.-old WT and *Ad-Lkb1* mice, three mice for each genotype. Gene expression was analyzed by microarray with Agilent SurePrint G3 Mouse GE 8 × 60 K chip as previously described ([@bb0045]). Genes with an average fold change ≥ 1.5folds were selected for pathway analysis through the DAVID Bioinformatics Resources 6.8 as instructed ([@bb0100], [@bb0105]).

2.8. Real-time PCR {#s0050}
------------------

Total RNA was extracted from tissues using Trizol Reagent according to the manufacturer\'s instructions. RNA was treated with RNase-free DNase l to remove genomic DNA. The purity and concentration of total RNA were measured by a spectrophotometer (Nanodrop 3000, Thermo Fisher) at 260 nm and 280 nm. Ratios of absorption (260/280 nm) of all samples were between 1.8 and 2.0. Then 3 μg of total RNA were reversed transcribed using random primers and MMLV reverse transcriptase. Real-time PCR was carried out with a Roche Lightcycler 480 PCR System using SYBR Green Master Mix and gene-specific primers. The 2^−∆∆CT^ method was used to analyze the relative changes of gene expression normalized against 18S rRNA as internal control.

2.9. Protein Extraction and Western Blot Analysis {#s0055}
-------------------------------------------------

Total protein was isolated from tissues using RIPA buffer contains 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate and 0.1% SDS. Protein concentrations were measured using BCA Protein Assay Reagent (Thermo scientific). Proteins were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), transferred to a polyvinylidene fluoride (PVDF) membrane (Millipore Corporation), blocked in 5% fat-free milk for 1 h at RT, then incubated with first antibodies (diluted in 5% milk) overnight at 4 °C. Lkb1 (sc-32245, 1:1000, RRID: [AB_6278](nif-antibody:AB_6278){#ir1010}) and GAPDH (sc-32233, 1:1000, RRID: [AB_627679](nif-antibody:AB_627679){#ir0005}) antibodies are from Santa Cruz biotechnology. mTOR (\#2972, 1:1000, RRID: [AB_330978](nif-antibody:AB_330978){#ir0010}) antibodies are from Cell signaling technology. The horseradish peroxidase (HRP)-conjugated secondary antibody (anti-rabbit IgG, 111-035-003, RRID: [AB_10015289](nif-antibody:AB_10015289){#ir0015} or anti-mouse IgG, 115-035-003, RRID: [AB_10015289](nif-antibody:AB_10015289){#ir0020}, Jackson ImmunoResearch) were diluted 1: 10,000. Immunodetection was performed using enhanced chemiluminescence western blotting substrate (Santa Cruz biotechnology) and detected by FluorChem R System (ProteinSimple). Results shown in the figures are representative results from at least three independent experiments.

2.10. Data Analysis {#s0060}
-------------------

All data are presented as means ± S.E.M. Comparisons were made by two-tailed Student\'s *t*-tests. Effects were considered significant at P \< 0.05.

2.11. Data and Materials Availability {#s0065}
-------------------------------------

The microarray reported in this paper has been deposited in the Gene Expression Omnibus database (GEO: [GSE89348](ncbi-geo:GSE89348){#ir0025}).

3. Results {#s0070}
==========

3.1. *Ad-Lkb1* Mice Develop Hindlimb Paralysis Starting From 8-month Old {#s0075}
------------------------------------------------------------------------

We generated *Adipoq-Cre/Lkb1*^*flox/flox*^ (*Ad-Lkb1*) mice to specifically knock out (KO) Lkb1 in adipocytes ([Fig. 1](#f0005){ref-type="fig"}a). Young *Ad-Lkb1* mice exhibited BAT (but not WAT) hypertrophy, resulting in better glucose tolerance, insulin sensitivity and resistance to high fat diet induced obesity ([@bb0230]). Interestingly, the *Ad-Lkb1* mice developed dysfunction of both hind limbs and became paralyzed starting at 8 months old. This was characterized by clenching of both hind limbs to the body when suspended by the tail ([Fig. 1](#f0005){ref-type="fig"}b), dragging, clumsy and autonomous twitching of both hind limbs, and inability to maintain body balance ([Fig. 1](#f0005){ref-type="fig"}c and [movie S1](#ec0005){ref-type="supplementary-material"}). Furthermore, footprint assay showed that the forelimbs of *Ad-Lkb1* mice maintained normal mobility but the hindlimbs could not move forward normally ([Fig. 1](#f0005){ref-type="fig"}d). On average, 18% of the male *Ad-Lkb1* mice exhibited hindlimb paralysis at 9 months old, reaching 100% at 11-month-old ([Fig. 1](#f0005){ref-type="fig"}e). The *Ad-Lkb1* females developed paralysis about one month earlier than did the males, with about 22% mice paralyzed at 8 months old, and 100% at 10-month-old ([Fig. 1](#f0005){ref-type="fig"}f). These data demonstrate that *Ad-Lkb1* mice develop the chronic and late onset hindlimb paralysis.

3.2. *Ad-Lkb1* KO Leads to Axon Degeneration in the Sciatic Nerve {#s0080}
-----------------------------------------------------------------

We further examined the etiology of paralysis in *Ad-Lkb1* mice. Axon abnormality and subsequent degeneration of sciatic nerve is a common cause of hindlimb paralysis ([@bb0075]). Semi-thin transverse sections of sciatic nerve showed lower fiber density and fewer myelinated axons in the KO compared to WT mice ([Fig. 2](#f0010){ref-type="fig"}a and b). Transmission electron microscopy (TEM) revealed that axons of KO mice exhibited abnormal morphology characterized by demyelination, myelin sheath de-compaction, myelin inflodings, axon swelling and increased endoneurial space ([Fig. 2](#f0010){ref-type="fig"}c). Measurement of g-ratio, the ratio of inner axonal diameter to outer diameter of myelin sheath, revealed a trend of demyelination and decompaction in KO sciatic nerves, manifested by wider dispersal of g-ratios ([Fig. 2](#f0010){ref-type="fig"}d). In addition, axon diameter distribution showed a shift from medium-large axons to smaller axons in KO mice ([Fig. 2](#f0010){ref-type="fig"}e). Quantitatively, the *Ad-Lkb1* sciatic nerves had significantly fewer normally myelinated axons and more abnormally myelinated axons compared to those of WT mice ([Fig. 2](#f0010){ref-type="fig"}f). Consistently, KO mice had higher percentage of abnormal axons than WT ([Fig. 2](#f0010){ref-type="fig"}g). At the molecular level, the mRNA levels of myelination related genes, including apolipoprotein E (*Apoe*), myelin protein zero (*Mpz*) and peripheral myelin protein 22 (*Pmp22*) were downregulated in the sciatic nerves of *Ad-Lkb1* mice compared to the WT counterparts ([Fig. 2](#f0010){ref-type="fig"}h). At the functional level, axon demyelination in the *Ad-Lkb1* sciatic nerve significantly reduced the amplitude of compound action potentials (CAP) ([Fig. 2](#f0010){ref-type="fig"}i). These results suggest that Lkb1 KO in adipocytes induces degeneration and functional loss of axons in the sciatic nerve.Fig. 1Ad-Lkb1 mice develop hindlimb paralysis starting at 8-month-old. (a) Targeting strategy for adipocyte-specific deletion of Lkb1. Black box represents deleted exons and triangles represent LoxP sites. (b and c) Representative images of WT and paralyzed KO mice (8-month-old). KO mice clench the hind limbs to the body when suspended by the tail (b), drag hind limbs and are unable to keep the body balance (c). (d) Foot-prints of a paralyzed KO and a normal WT mouse (9-month-old), fore-paws were immersed in red ink and hind limbs were immersed in blue ink. (e and f) Occurrence rate of paralysis in WT and KO male (n = 11 pairs) and female (n = 14 pairs) mice. The number of samples are biological replicates.Fig. 1Fig. 2Ad-Lkb1 KO leads to axon abnormality in sciatic nerves. (a) Semi-thin transverse sections of sciatic nerve showing lower fiber density in KO mice than WT mice. Scale bar: 100 μm. (b) Total number of myelinated axon per sciatic nerve in WT and KO mice (N = 4 pairs). (c) Ultrastructure transmission electron microscopy (TEM) images showing compact and completely myelinated fibers in WT mice. KO sciatic nerves had increased endoneurial space (red asterisk) and axonal fibers with myelin disruption, decompaction (red arrow) and folding (blue arrow). (d and e) G-ratio (d) and axon size distribution (e) of myelinated axons in WT and KO sciatic nerve were analyzed as described in method. N = 4 pairs. WT = 333 axons, KO = 250 axons. (f and g) Numbers of normal, abnormal myelinated axons per area (f) and percentages of abnormal axons (g). Three random pictures of each sample were counted (N = 4 pairs). (h) Relative mRNA levels of myelination related genes (*Apoe*, *Mpz*, *Krox24* and *Pmp22*) in WT (N = 4) and paralyzed KO mice (N = 3). (i) CAP (compound action potential) amplitude of WT (N = 4) and paralyzed KO (N = 3) mice. All the mice are 8--12 months old and the number of samples are biological replicates. Error bars: S.E.M., \*P \< 0.05, \*\*P \< 0.01, \*\*\*P \< 0.001 (Student\'s *t*-test).Fig. 2

We also examined if sciatic nerve degeneration affects hind limbs muscles. KO mice had significantly lower muscle weights than did the control mice (Fig. S1a). H&E staining revealed that muscle fiber size appeared smaller in muscles of paralyzed *Ad-Lkb1* mice (Fig. S1b). In addition, the complexity of neuromuscular junction (NMJ) was reduced in Lkb1 KO mice compared with that of WT mice (Fig. S1c). Furthermore, fiber type immunostaining in gastrocnemius (GAS) and tibialis anterior (TA) muscles showed that the Lkb1 KO contained more type IIA muscle fibers in GAS (blue box region) and TA muscles, compared to those of WT mice (Fig. S1d). Similarly, the extensor digitorum longus (EDL) and soleus (SOL) muscles of the Lkb1 KO mice contained more type IIA fibers, but fewer type IIX/IIB fibers compared with the corresponding muscles of WT mice (Fig. S1e). These results are consistent with previous observations in human peripheral neuropathies in which demyelination and abnormality in sciatic nerve lead to muscle atrophy, accompanied by myofiber type switching toward slower types and reduced complexity of NMJ ([@bb0130]).

3.3. *Ad-Lkb1* KO Induces Expression of Pro-inflammatory Genes in Brown Adipocyte and Macrophage Infiltration in Sciatic Nerves {#s0085}
-------------------------------------------------------------------------------------------------------------------------------

Schwann cells constitute the major cell type in the sciatic nerve, and form the myelin sheath that insulates and functionally supports the peripheral nerve fibers ([@bb0115]). The severe sciatic nerve abnormality in the *Ad-Lkb1* mice is similar to the phenotype of mice with Schwann cell specific deletion of Lkb1 ([@bb0185]; [@bb0040]), raising the possibility that the Adipoq-Cre may induce ectopic KO of *Lkb1* in Schwann cells. To examine the possibility, we performed Cre/LoxP lineage tracing using the Adipoq-Cre and Rosa26^Td-Tomato^ (*Adipoq-Td*) reporter mice. Td (a red fluorescent protein) signals were found in classical WAT and BAT, but not in the spinal cord, liver, spleen, muscle, heart, or brain (Fig. S2a). Although Td signals were observed in sciatic nerves along the periphery (Fig. S2b), they are limited to epineurial adipocytes that were marked by Bodipy staining (Fig. S2c and d). Direct labeling the Schwann cells in cross and longitudinal sections of sciatic nerve with the S100b antibody revealed that the Td positive cells were never positive for S100b (Fig. S2e). These data indicate that *Adipoq-cre* specifically marks adipocytes but not Schwann cells, and exclude the possibility that the paralysis phenotype of Ad-Lkb1 mice is due to ectopic deletion of Lkb1 in Schwann cells.

A main phenotype of the *Ad-Lkb1* mice is brown fat hypertrophy ([@bb0230]), which may boost adipokine secretion. We therefore hypothesized that *Lkb1* null adipocytes induce sciatic nerve dysfunction by a paracrine/endocrine mechanism. To test this hypothesis, we first sought to understand how BAT hypertrophy alters gene expression, through microarray analysis of BAT from 3-month-old WT and Ad-Lkb1 mice, before development of hindlimb paralysis ([Fig. 3](#f0015){ref-type="fig"}a and b). Pathway analysis of the microarray data revealed that Lkb1 KO upregulated several inflammation-related pathways, including "Chemokine signaling", "Toll-like receptor signaling", "Jak-STAT signaling", "Cytokine-cytokine receptor interaction" and "ECM-receptor interaction" pathways ([Fig. 3](#f0015){ref-type="fig"}a and b). Further qPCR analysis confirmed the higher mRNA levels of many inflammatory cytokines (Tumor necrosis factor a, *Tnfa*; C-C motif chemokine ligand 2, *Ccl2*, also called *Mcp1*; C-C motif chemokine ligand 7, *Ccl7*, also called *Mcp3*) in BAT from 2, 6, 8-month-old KO mice, prior to onset of hindlimb paralysis ([Fig. 3](#f0015){ref-type="fig"}c). To verify if Lkb1 KO cell-autonomously upregulates the expression of pro-inflammatory cytokines in brown adipocytes, we cultured brown adipocytes from WT and Ad-Lkb1 mice and found that *Tnfa*, *Ccl2* and *Ccl7* were expressed at higher levels in Lkb1 KO compared to WT adipocytes ([Fig. 3](#f0015){ref-type="fig"}d). Interestingly, mRNA levels of these inflammatory genes were not affected by Lkb1 KO in white adipose tissues (inguinal WAT, iWAT and epididymal WAT, eWAT) that did not undergo hypertrophy (Fig. S3a and b), suggesting that hypertrophy is the main trigger of adipocyte inflammation. Consistent with previous observation that epineurial adipocytes exhibit brown adipocytes characteristics ([@bb0210]), we found that epineurial adipocytes express Ucp1 (Fig. S4a), a specific marker of brown adipocytes. To determine if epineurial adipocytes are inflamed in the Ad-Lkb1 mice, we examined mRNA levels of these inflammatory cytokines in the sciatic nerve. Indeed, mRNA levels of *Tnfa*, interleukin 1b (*Il1b*) tended to be higher in *Ad-Lkb1* than in WT sciatic nerves (Fig. S4b). The mRNA levels of *Ccl2* were \~ 4 folds higher in *Ad-Lkb1* than in WT sciatic nerves (Fig. S4b). Collectively, these results indicated that Lkb1 KO specifically induced expression of pro-inflammatory genes in brown adipocytes including epineurial adipocytes, but not in white adipocytes.Fig. 3Ad-Lkb1 KO induces inflammation in brown adipocyte and macrophage recruitment into sciatic nerve. (a) Microarray volcano plot of genes significantly up- or down-regulated in Ad-Lkb1 (N = 3) versus WT BAT (N = 3). Colored dots or triangles denote genes in the indicated pathways. (b) Heat map showing relative levels (fold changes = KO signal/WT signal) of the representative genes from pathways listed in A. (c and d) Relative mRNA levels of *Lkb1, Tnfa, Ccl2 and Ccl7* genes in BAT (c) from 2 month (N = 4 pairs), 6 month (N = 4 pairs), 8 month (N = 5 pairs) old mice and mature brown adipocyte (d, N = 4 repeats), determined by qPCR. (e and f) Relative mRNA levels of CD-68 (e, WT, N = 5, KO, N = 6) and immunofluorescence labeling of CD68-expressing cells (f, N = 3 pairs, three random pictures of each sample were counted) in sciatic nerve from WT and paralyzed KO mice. Error bars: S.E.M., \*P \< 0.05, \*\*P \< 0.01, \*\*\*P \< 0.001. Scale bar: 100 μm. The number of samples are biological replicates.Fig. 3

We next asked how BAT inflammation induces sciatic nerve degeneration and dysfunction. Chemokines, including Ccl2 and Ccl7, provide directional cues and induce infiltration of inflammatory macrophages ([@bb0145]). Notably, the macrophage marker *CD68* was also expressed at higher levels in *Ad-Lkb1* than in WT sciatic nerves ([Fig. 3](#f0015){ref-type="fig"}e), suggesting macrophage infiltration. Indeed, there were more CD68 positive cells (macrophages) in cross section of sciatic nerves of Lkb1 KO mice than in those of WT mice ([Fig. 3](#f0015){ref-type="fig"}f). In addition, the expression of inflammatory genes was elevated in spinal cords of Ad-Lkb1 mice only after, but not prior to, the development of paralysis (Fig. S5a and b). This observation is consistent with the notion that sciatic nerve injury can lead to inflammation in spinal cord ([@bb0080]). These results indicate that pro-inflammatory cytokines from *Lkb1* null brown adipocytes promote macrophage infiltration into the sciatic nerve, leading to nerve degeneration.

3.4. Anti-Inflammation Treatment Delays the Occurrence of Paralysis {#s0090}
-------------------------------------------------------------------

To confirm if inflammation and macrophage infiltration leads to hindlimb paralysis in *Ad-Lkb1* KO mice, we treated pre-symptomatic mice with the macrophage depletion agent clodrosome ([Fig. 4](#f0020){ref-type="fig"}a). Immunostaining confirmed that clodrosome reduced the abundance of macrophages in the sciatic nerve ([Fig. 4](#f0020){ref-type="fig"}b). Clodrosome also reduced the mRNA levels of *CD68* and several pro-inflammatory chemokines ([Fig. 4](#f0020){ref-type="fig"}c). These data indicate that clodrosome effectively depleted macrophages and reduced inflammation in the sciatic nerve.Fig. 4Clodrosome-mediated depletion of macrophages delays the occurrence and ameliorates the severity of paralysis. (a) Experimental design for clodrosome treatment. IP: intraperitoneal. (b and c) CD68 immunostaining (b, N = 3 pairs, three random pictures were counted from each mice) and relative mRNA levels of pro-inflammatory genes (c, N = 5 pairs) of sciatic nerve from 3 treatment groups: WT, KO + Vehicle and KO + Clodros. Clodros: Clodrosome. (d) Mice behavioral scores before (upper) and after (bottom) treatment in WT, KO + Vehicle and KO + Clodros groups, N = 5 pairs of age/sex-matched littermates (L1-L5). Mild paralysis: clenching of hind limbs to the body when suspended by the tail, dragging hind limbs and moving slowly. Severe paralysis: hind limbs can\'t move and the mice are unable to keep body balance. (e) Distance (upper) and speed (bottom) of mice ran on a treadmill after clodrosome treatment for 4 weeks. N = 5 pairs. (f) CAP amplitude for WT (N = 6), KO + Vehicle (N = 4) and KO + Clodros (N = 5) groups. The number of samples are biological replicates. Error bars: S.E.M., \*P \< 0.05, \*\*P \< 0.01, \*\*\*P \< 0.001, WT compared with KO + Vehicle groups. ^\#^P \< 0.05, ^\#\#^P \< 0.01, KO + Vehicle compared with KO + Clodros groups (Student\'s *t*-test). Scale bar: 100 μm.Fig. 4

Next, we assessed the histology of sciatic nerve and motor function of mice before and after clodrosome treatment in both WT and *Ad-Lkb1* littermates (5 L labeled as L1-L5). Strikingly, clodrosome prevented the development or ameliorated the severity of paralysis in the *Ad-Lkb1* mice ([Fig. 4](#f0020){ref-type="fig"}d). Clodrosome also improved the exercise capacity (running distance and speed on treadmill) of the *Ad-Lkb1* mice ([Fig. 4](#f0020){ref-type="fig"}e). At the structural level, clodrosome partially rescued the abnormal morphology of axon in *Ad-Lkb1* sciatic nerves (Fig. S6a). Both the number and percentage of normal myelinated axons were increased by clodrosome treatment (Fig. S6b). Compared with vehicle control treatment, clodrosome treatment also induced a shift of axon size from small-medium axons to larger axons (Fig. S6c). Furthermore, clodrosome significantly improved the CAP amplitude of sciatic nerve ([Fig. 4](#f0020){ref-type="fig"}f). Together, these results demonstrate that inflammation and macrophage infiltration result in sciatic motor axonal abnormality and development of hindlimb paralysis in *Ad-Lkb1* mice.

3.5. Lkb1 Ablation Induces Inflammation through Activation of mTOR Signaling {#s0095}
----------------------------------------------------------------------------

Deletion of Lkb1 in adipose tissues has been reported to activate the mTOR pathway in BAT through inhibition of AMPK activity ([@bb0230]). Consistently, *Ad-Lkb1* KO in BAT but not in WAT reduced the phosphorylation of AMPK, but increased the level of pS6/S6, an indicator of mTOR signaling (Fig. S7a-b). We hypothesized that activation of mTOR in brown adipocytes promote their production of inflammatory cytokines, as previously reported ([@bb0305]). To test this hypothesis, we inhibited the mTOR pathway by rapamycin ([Fig. 5](#f0025){ref-type="fig"}a) and found that rapamycin treatment protected KO mice from development of hindlimb paralysis ([Fig. 5](#f0025){ref-type="fig"}b). In contrast, all the KO mice treated with vehicle control developed mild or sever hindlimb paralysis ([Fig. 5](#f0025){ref-type="fig"}b). This was further confirmed by exercise performance test, showing improved motor functions after rapamycin treatment ([Fig. 5](#f0025){ref-type="fig"}c). Moreover, rapamycin normalized the expression of inflammation-related genes and nerve conduction in sciatic nerve of KO mice to levels similar to those of WT mice ([Fig. 5](#f0025){ref-type="fig"}d and e). These data indicate that *Lkb1* knockout induces adipocyte inflammation through activation of mTOR pathway.Fig. 5Rapamycin rescues the Ad-Lkb1 induced hindlimb paralysis. (a) Experimental design for rapamycin treatment. 7--8 months old mice were injected with Rapamycin once a day for one week and subsequently injected every other day for 4 weeks, then collecting samples. (b) Mice behavioral scores before (upper) and after (bottom) treatment in WT, KO + Con (Control) and KO + Rapa (Rapamycin) groups, N = 3 pairs of age/sex-matched littermates (L1-L3). Mild paralysis: clenching of hind limbs to the body when suspended by the tail, dragging hind limbs and moving slowly. Severe paralysis: hind limbs can\'t move and the mice are unable to keep body balance. (c) Distance (left) and speed (right) of mice ran on a treadmill before treatment (upper) and after Rapamycin treatment (bottom) for 5 weeks. N = 3 pairs, 7--8 months old. (d) Relative mRNA levels of pro-inflammatory factors and chemokines of BAT and sciatic nerve in WT (N = 3), KO + Con (N = 3) and KO + Rapa (N = 3) groups. (e) CAP amplitude for WT (N = 3), KO + Con (N = 3) and KO + Rapa (N = 3) groups. \*P \< 0.05, \*\*P \< 0.01, WT compared with KO + Con mice; ^\#^P \< 0.05, ^\#\#^P \< 0.01, KO + Con compared with KO + Rapa mice (Student\'s *t*-test). The number of samples are biological replicates. Error bars: S.E.M.Fig. 5Fig. 6Ad-Lkb1 induces hindlimb paralysis through activation of mTOR signaling. (a and b) The mRNA and protein expression of Lkb1 and mTOR in BAT from WT (N = 4) and DK (N = 5) mice (8-month-old), \*\*P \< 0.01. (c) Representative images and foot-print of WT, Lkb1 KO and Lkb1/mTOR DK mouse (10-month-old). Fore-paws were immersed in red ink and hind limbs were immersed in blue ink. (d) Relative mRNA levels of pro-inflammatory factors and chemokines of BAT in WT (N = 3), KO (N = 3) and DK (N = 3) groups. (e) CD68 immunostaining of sciatic nerve from WT, KO and DK mice, N = 3 pairs (three random pictures were counted from each mice), scale bar: 100 μm. (f and g) sciatic nerve TEM images (f) and axon size distribution (g) of WT, KO and DK mice (male, 9-month-old), N = 3 pairs. (h and i) Numbers of normal, abnormal myelinated axons per area (h) and percentages of abnormal axons (i), N = 3 pairs. (j) CAP amplitudes of WT (N = 4), KO (N = 7) and DK (N = 6) from 8--10-month old mice. The number of samples are biological replicates. Error bars: S.E.M., \*P \< 0.05, \*\*P \< 0.01, KO compared with WT mice; ^\#^P \< 0.05, ^\#\#^P \< 0.01, DK compared with KO mice (Student\'s *t*-test).Fig. 6

To further validate if activation of mTOR pathway is responsible for adipocyte inflammation in *Ad-Lkb1* mice, we generated Adipoq-Cre/*Lkb1*^*f/f*^/*mTOR* ^*f/f*^ double knockout (DK) mice to concomitantly delete *Lkb1* and *mTOR* in adipocytes ([Fig. 6](#f0030){ref-type="fig"}a and b). Strikingly, DK mice were behaviorally normal and completely free of paralysis through the age of 2-year-old ([Fig. 6](#f0030){ref-type="fig"}c and [movie S2](#ec0010){ref-type="supplementary-material"}). DK also normalized the expression of proinflammatory genes in BAT to levels similar to those of WT ([Fig. 6](#f0030){ref-type="fig"}d). Furthermore, DK mice had reduced infiltration of CD68 positive macrophages in the sciatic nerve ([Fig. 6](#f0030){ref-type="fig"}e). At the ultrastructural level, sciatic nerve axons in DK mice had completely normal morphology with myelin sheath remained compact ([Fig. 6](#f0030){ref-type="fig"}f) and had normal size distribution of axons ([Fig. 6](#f0030){ref-type="fig"}g). Quantitatively, the number and percentage of abnormally myelinated axons were comparable in DK and WT mice, much lower than those of KO mice ([Fig. 6](#f0030){ref-type="fig"}h and i). DK mice also had significant higher nerve conductance compared to KO mice, though it remained lower than that of the WT ([Fig. 6](#f0030){ref-type="fig"}j). These results indicate that Lkb1 deletion induced adipocyte inflammation through activation of the mTOR pathway.

4. Discussion {#s0100}
=============

In this study, we found that ablation of Lkb1 in adipocytes (including epineural adipocytes) induced inflammation and macrophage invasion in sciatic nerves, leading to severe sciatic axon abnormality and hindlimb paralysis. Accordingly, macrophage depletion in *Ad-Lkb1* mice delays the development of hindlimb paralysis. We further provide genetic evidence that *Lkb1* KO induces inflammation through activation of mTOR pathway. These results establish a role of brown adipocytes in regulating the function of peripheral nerve ([Fig. 7](#f0035){ref-type="fig"}) and their inflammation may lead to peripheral neuropathies.Fig. 7Schematic summary of Ad-Lkb1 induced inflammation and axonal abnormality in sciatic nerves through mTOR pathway.Fig. 7

Hindlimb paralysis is often a consequence of peripheral nerve neuropathy. Earlier clinical observations reported that the most common cause of peripheral neuropathy is diabetes and obesity ([@bb0280]). However, *Ad-Lkb1* mice are neither obese nor diabetic ([@bb0230]). On the contrary, *Ad-Lkb1* mice have higher energy expenditure, better glucose tolerance and insulin sensitivity, and are more resistant to high fat diet (HFD)-induced obesity prior to development of paralysis ([@bb0230]). In addition, clinical data suggest that male diabetic patients are more vulnerable to develop peripheral neuropathies than females ([@bb0005]). In contrast, *Ad-Lkb1* females had earlier onset of paralysis than males, suggesting that continuous chronic inflammation induces more severe tissue damages in females than in males ([@bb0060]). Therefore, we exclude the possibility that hindlimb paralysis in the *Ad-Lkb1* mice is a result of diabetes or systemic metabolic dysfunction.

The late onset of paralysis suggests that the magnitude of BAT hypertrophy-induced inflammation is low grade, which may not reach a threshold level to cause systemic inflammatory response and nerve degeneration in young animals. Chronic low-grade inflammation is similarly associated with white fat expansion and obesity, leading to neuropathy ([@bb0155]; [@bb0190]). Interestingly, low levels of adipocyte inflammation are essential for the healthy expansion of adipose tissues ([@bb0015]). However, sustained chronic inflammation could slowly accumulate and lead to side effects in the long run. In the Ad-Lkb1 mice, the sustained inflammation of BAT and production of inflammatory cytokines may have reached a threshold to signal macrophage infiltration and sciatic nerve degeneration by middle ages.

Degeneration of sciatic nerve in Ad-Lkb1 KO mice is manifested by reduced number of axons, abnormal axonal morphology, increased number of small axons and loss of CAP. These changes of sciatic nerve are sufficient to compromise its function. Although the average g-ratio in KO mice is not higher than WT, the g-ratios are more widely scattered (dispersed), suggesting de-compaction (which leads to a smaller g-ratio) and demyelination (which leads to larger g-ratio). Although the severe sciatic nerve abnormality in the *Ad-Lkb1* mice is similar to the phenotype of mice with Schwann cell specific deletion of *Lkb1* ([@bb0040]; [@bb0185]), the etiology in the Ad-Lkb1 model is not due to ectopic deletion of Lkb1 in Schwann cells. First, lineage tracing study fails to detect any ectopic *Adipoq-cre* activity in Schwann cells. Second, the late onset of paralysis in Lkb1 KO mice indicates that initial myelination is normal in the KO mice, and further suggests that the peripheral neuropathy is not primarily caused by defects in Schwann cells.

The lineage tracing analysis indicates that *Ad-Lkb1*mediates the deletion of *Lkb1* in both white and brown adipocytes. Interestingly, disruption of *Lkb1* only leads to upregulation of proinflammatory cytokines in brown, but not in white, adipocytes. This may be due to hypertrophy of BAT, but not WAT, in Ad-Lkb1 mice. Alternatively, BAT-specific inhibition of AMPK and activation of mTOR (independent of BAT hypertrophy) could also explain the upregulation of inflammatory cytokines in BAT but not WAT. Our Ucp1 expression analysis and a previous study ([@bb0210]) suggest that epineurial adipocytes are similar to classic brown adipocytes, which explains the elevated expression of inflammatory genes in sciatic nerve. In theory, proinflammatory cytokines from both classical and epineurial brown adipocytes may have contributed to the development of hind limb paralysis. Proinflammatory factors from classic BAT may be secreted into the circulation and delivered to the sciatic nerve. Supporting this notion, adipokines, such as leptin ([@bb0055]), resistin ([@bb0050]) and adiponectin ([@bb0090]) from WAT, are reported to regulate neuroinflammation through the blood circulation ([@bb0165]). On the other hand, local inflammation medicated by epineurial brown adipocytes may directly trigger macrophage infiltration and sciatic nerve degeneration. Supporting this notion, previous research reported that leptin secreted from epineurial adipocytes of the sciatic nerve is critical for the development of tactile allodynia through macrophage activation in mice after partial sciatic nerve ligation ([@bb0150]). Future studies using epineurial adipocyte-specific or classical brown adipocyte-specific Cre to delete Lkb1 will directly address the relative contribution of BAT and epineurial fat inflammation to peripheral nerve disease. Given lack of the specific molecular makers to distinguish classical intrascapular and epineurial brown adipocytes, this remains a challenging task at present time.

Ccl2 and Ccl7 cytokines are reported to mediate recruitment of monocytes and macrophages ([@bb0250]). Consistently, increased *Ccl2/7* expression and macrophage infiltration was observed in sciatic nerves. Macrophages can be further divided into early proinflammatory M1 and late anti-inflammatory M2 macrophages ([@bb0110]). M1 efficiently produces toxic effector molecules (ROS and NO) and inflammatory cytokines (Il-1β, Tnfa, Il-6) ([@bb0095]). Our qPCR results identified an elevated expression of M1 markers and thus pointed infiltrated macrophage to M1 macrophages. Clodrosome is widely used to specifically deplete macrophages, including macrophages in sciatic nerves ([@bb0335]). We show that clodrosome treatment normalized the expression of pro-inflammatory genes and delayed the occurrence of paralysis. These results demonstrate that inflammation of *Ad-Lkb1* KO leads to hindlimb paralysis.

Interestingly, conditional KO of Lkb1 driven by rat insulin 2 promoter (RIP2)-Cre (RIP2-Cre/*Lkb1* ^*flox/flox*^ mice) also results in paralysis ([@bb0260]). However, the etiology of hindlimb paralysis in the RIP2-Cre/*Lkb1* ^*flox/flox*^ mice was due to ectopic deletion of Lkb1 in the spinal cord and brain that affected neuronal polarity ([@bb0260]). In contrast, our *adipoq-cre* lineage tracing excluded the possibilities of Cre activity or adipocyte presence in the spinal cord. Other studies also support the notion that adipocytes are only found in the epineurium of peripheral nerves, but not in the spinal cord ([@bb0215]; [@bb0120]; [@bb0285]). It was reported that sciatic nerve injury could disrupt blood--spinal cord barrier, leading to secondary inflammation in the spinal cord ([@bb0080]). Consistent with this notion, we observed spinal cord inflammation only after, but not before, the development of paralysis. Thus, the inflammatory responses in the spinal cord are secondary to sciatic nerve lesions.

The rescue of hindlimb paralysis by rapamycin treatment or concomitant KO of mTOR in the Ad-Lkb1 mice suggests that Lkb1 KO activates mTOR to elicit inflammatory responses. It has been reported that deletion of Lkb1 in adipose tissues reduces phosphorylation of AMPK and augments mTOR signaling ([@bb0230]), which plays a pivotal role in regulating immune responses ([@bb0295]). This is also supported by the observation that mice treated with rapamycin (mTOR inhibitor) have enhanced anti-inflammation activity ([@bb0305]). Furthermore, several groups have reported that mTORC1 inhibition reduces Ccl2 secretion by immune cells, including monocytes, macrophages and dendritic cells ([@bb0295]). Consistently, we found that Lkb1 KO-induced activation of mTOR pathway upregulates *Ccl2* expression in brown adipocyte. Alternatively, deletion of Lkb1 may have led to inflammation through suppression of autophagy in brown adipocytes. It has been reported that inhibition of AMPK activity results in loss of autophagy through activation of mTOR signaling to phosphorylate Ulk1 Ser 757 and disrupt the interaction between AMPK and Ulk1, a key regulator for autophagy ([@bb0200]; [@bb0125]). Also, perturbations in autophagy-protein-dependent functions in immunity contribute to chronic inflammatory diseases and autoimmune diseases ([@bb0140]; [@bb0330]). Although our data confirm that deletion of Lkb1 induces inflammation through mTOR pathway in adipocytes, the specific involvement of autophagy in this process warrants future investigation.

The following are the supplementary data related to this article.Supplementary movie S1Movement of WT mouse (upper) and initial paralyzed *Ad-Lkb1* mouse (bottom) in the new cages.Supplementary movie S1Supplementary movie S2Movement of WT (left), initial paralyzed *Ad-Lkb1* (middle) and DK (right) mice in the new cages.Supplementary movie S2Supplementary figuresImage 1
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